ASIF was established in 1988 to increase public awareness of Ankylosing Spondylitis and to disseminate knowledge of the disease around the world.
ASIF is a Charity registered with the Charity Commission for England and Wales Charity # 1173902
Ankylosing Spondylitis (AS)A rheumatic inflammatory disease primarily affecting the spine and sacroiliac joints, is also called ‘Morbus Bechterew’ in some European countries. You will find this popular name of the disease in the name of some European AS societies.
Related DiseasesAnkylosing spondylitis sometimes overlaps with psoriasis, with an inflammatory bowel disease (Crohn’s disease or ulcerative colitis), or with the eye conditions uveitis or iritis.
ASIF is a member of the People with Arthritis/Rheumatism in Europe (PARE), a standing committee of the European League Against Rheumatism (EULAR).
We cooperate with the Assessment of SpondyloArthritis international Society (ASAS), the international working group of ankylosing spondylitis researchers.
ASIF has 38 Patient Organisation Members from 36 countries around the world.
Corportate SponsorsASIF is grateful for the support of its industry partners:
Aims of Asif
- Exchange of information and experiences among the member societies,
- Cooperation in international research projects,
- Exchange of articles for publication in the journals of the member societies,
- Support of the development of newly formed societies,
- Make contact with ankylosing spondylitis stakeholders in countries where an AS society does not yet exist
This version of the constitution was accepted by the ASIF Council at its 12th meeting held in Moscow (Russia) on 8th October 2016 and amended at a Special General Meeting in Madrid (Spain) on 16th June 2017.
Scientific Advisor: DR. UTA KILTZ Germany
President: ZHIVKO YANKOV Bulgaria
Treasurer: HEDLEY HAMILTON United Kingdom
Secretary: ANDRI PHOKA Cyprus
Trustee: LEE SEUNG-HO South Korea
Trustee: DR. TUNCAY DURUÖZ Turkey
Trustee: RUTA GRIGIENE Lithuania
Trustee: RAJ MAHPATRA United Kingdom
Executive Support to the Board: JO DAVIES United Kingdom